Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 76420-923

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 76420-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram of bupropion hydrochloride, showing the molecular arrangement including a chlorophenyl group, a ketone, and a tertiary amine, along with the hydrochloride component.*

FDA Label Image

Label (Label)

Five labels for Bupropion Hydrochloride XL ER Tablets 150 mg by Asclemed USA, Inc., relabeled by Enovachem Pharmaceuticals. Each label shows varying package sizes of 30, 60, 90, 100, and 500 tablets with details including NDC codes, manufacturer Teva Pharmaceuticals, and storage instructions. Tablets are described as white to off-white, round, film-coated extended-release.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.